Cargando…

Clot-in-transit cardiopulmonary thrombosis during convalescent phase of COVID-19

Detalles Bibliográficos
Autores principales:	Karippacheril, John George, Jain, Amit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Anesthesiologists 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831433/ https://www.ncbi.nlm.nih.gov/pubmed/34225401 http://dx.doi.org/10.4097/kja.21199

Ejemplares similares

Acute Portal Vein Thrombosis during COVID-19 Convalescent Phase
por: Rahimian, Shoja, et al.
Publicado: (2022)

Ultrasound guided brachial block in a case of brachial plexus hypertrophy
por: Karippacheril, John George, et al.
Publicado: (2015)

Micro-Thrombosis, Perfusion Defects, and Worsening Oxygenation in COVID-19 Patients: A Word of Caution on the Use of Convalescent Plasma
por: Sanfilippo, Filippo, et al.
Publicado: (2021)

Convalescent plasma for COVID-19 considerations
por: Adiwinata Pawitan, Jeanne
Publicado: (2021)

Negative pressure pulmonary oedema and haemorrhage, after a single breath-hold: Diaphragm the culprit?
por: Karippacheril, John George, et al.
Publicado: (2010)

Data acquisition from S/5 GE Datex anesthesia monitor using VSCapture: An open source.NET/Mono tool
por: Karippacheril, John George, et al.
Publicado: (2013)

Videolaryngoscopy using an Android smartphone: A direct digital technique
por: Karippacheril, John George, et al.
Publicado: (2016)

In Reply — Micro-Thrombosis, Perfusion Defects, and Worsening Oxygenation in COVID-19 Patients: A Word of Caution on the Use of Convalescent Plasma
por: Klompas, Allan M., et al.
Publicado: (2021)

Cerebellar Hemorrhage in a Patient during the Convalescent Phase of Dengue Fever
por: Vargas-Sánchez, Ángel, et al.
Publicado: (2014)

Convalescent plasma in the management of COVID-19 pneumonia
por: Elbadawi, Ayman, et al.
Publicado: (2021)

How Safe Is COVID-19 Convalescent Plasma?
por: Franchini, Massimo, et al.
Publicado: (2021)

COVID-19 convalescent plasma therapy and immunodeficiency
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Unexplained thrombosis of the aortic arch with distal embolization in a patient with altered fibrin clot properties
por: Ciurus, Tomasz, et al.
Publicado: (2012)

Forced cough for witnessed extreme bradycardia in hip arthroplasty: a maneuver in extremis
por: Karippacheril, John George, et al.
Publicado: (2019)

‘Treatment of COVID-19 with convalescent plasma’ – Author’s reply
por: Wooding, Denise J., et al.
Publicado: (2021)

Use of convalescent plasma in COVID-19 patients in China
por: Zhu, M., et al.
Publicado: (2020)

Convalescent plasma (CP) therapy in patients with COVID-19
por: Cakir, Banu
Publicado: (2021)

In Reply—How Safe Is COVID-19 Convalescent Plasma?
por: Joyner, Michael J., et al.
Publicado: (2021)

Dynamics of faecal SARS-CoV-2 in infected children during the convalescent phase
por: Xing, Yuhan, et al.
Publicado: (2020)

Clot in Transit in a Patient with COVID-19: Transesophageal Echocardiographic Guidance of Mechanical Cardiopulmonary Resuscitation
por: Horowitz, James M., et al.
Publicado: (2021)

Insulin IP Calc: A smartphone application for insulin infusion protocol in Intensive Care Units
por: Karippacheril, John George, et al.
Publicado: (2015)

High-Dose Convalescent Plasma for Treatment of Severe COVID-19
por: Focosi, Daniele, et al.
Publicado: (2022)

Thrombosis and COVID-19 pneumonia: the clot thickens!
por: Price, Laura C., et al.
Publicado: (2020)

Ventilation and airway management during Cardiopulmonary Resuscitation in COVID-19 era
por: Sorbello, Massimiliano, et al.
Publicado: (2020)

Changes in patterns of extracorporeal cardiopulmonary resuscitation during the COVID-19 pandemic
por: Ng, Pauline Yeung, et al.
Publicado: (2021)

Factor IX alteration p.Arg338Gln (FIX Shanghai) potentiates FIX clotting activity and causes thrombosis
por: Wu, Wenman, et al.
Publicado: (2020)

Limitations of Safety Update on Convalescent Plasma Transfusion in COVID-19 Patients
por: Farag, Youssef M.K.
Publicado: (2020)

Convalescent plasma to treat COVID-19: Its challenges in Iraq's situation
por: Hashim, H.T.
Publicado: (2020)

Convalescent fecal microbiota transplantation as a possible treatment for COVID-19
por: Apartsin, Konstantin, et al.
Publicado: (2020)

Iran’s Experience in Establishing Convalescent Care Facilities for Patients With COVID-19
por: Maher, Ali, et al.
Publicado: (2020)

Challenges in the production of COVID-19 convalescent plasma- analysis of donor recruitment
por: Sekiya, Eliseo Joji, et al.
Publicado: (2021)

High-Dose Convalescent Plasma for Treatment of Severe COVID-19 (response)
por: De Santis, Gil C., et al.
Publicado: (2022)

COVID-19 vaccination: The impact on the selection criteria of the convalescent plasma donors
por: Bansal, N., et al.
Publicado: (2021)

The emergency use authorization for COVID‐19 convalescent plasma reduced mortality
por: Paneth, Nigel, et al.
Publicado: (2023)

In Reply — Limitations of Safety Update on Convalescent Plasma Transfusion in COVID-19 Patients
por: Joyner, Michael. J., et al.
Publicado: (2020)

Early and persistent viral clearance in COVID-19 patients treated with convalescent plasma
por: Franchini, Massimo, et al.
Publicado: (2021)

Neutralizing Autoantibodies to Type I Interferons in COVID-19 Convalescent Donor Plasma
por: Vazquez, Sara E., et al.
Publicado: (2021)

Covid-19 convalescent plasma and SARS-CoV-2 viral variants
por: Joob, B., et al.
Publicado: (2021)

Implementation of veno-venous extracorporeal membrane oxygenation in a COVID-19 convalescent
por: Gawda, Ryszard, et al.
Publicado: (2020)

COVID-19 infection and thrombosis
por: Srivastava, Swati, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v0erqb0ee2vmh1b0etrv47t16a